Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Integration of hepatitis C treatment at harm reduction centers in Georgia-Findings from a patient satisfaction survey.
Butsashvili M, Kamkamidze G, Kajaia M, Gvinjilia L, Kuchuloria T, Khonelidze I, Gogia M, Dolmazashvili E, Kerashvili V, Zakalashvili M, Shadaker S, Nasrullah M, Sonjelle S, Japaridze M, Averhoff F. Butsashvili M, et al. Among authors: dolmazashvili e. Int J Drug Policy. 2020 Oct;84:102893. doi: 10.1016/j.drugpo.2020.102893. Epub 2020 Jul 31. Int J Drug Policy. 2020. PMID: 32739613 Free PMC article.
Treatment of hepatitis C in primary health care in the country of Georgia.
Dolmazashvili E, Sharvadze L, Abutidze A, Chkhartishvili N, Todua M, Adamia E, Gabunia T, Shadaker S, Gvinjilia L, Arora S, Thornton K, Armstrong PA, Tsertsvadze T. Dolmazashvili E, et al. Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):175-178. doi: 10.1002/cld.1260. eCollection 2022 Nov. Clin Liver Dis (Hoboken). 2022. PMID: 36447909 Free PMC article.
IL28B favorable genotype and ultrarapid viral response as the earliest treatment predictors of a sustained viral response in a Georgian cohort infected with the hepatitis C genotype 1.
Karchava M, Sharvadze L, Chkhartishvili N, Nelson K, Gochitashivli N, Gatserelia L, Dvali N, Dolmazashvili E, Dzigua L, Badridze N, Zhamutashvili M, Tsertsvadze T. Karchava M, et al. Among authors: dolmazashvili e. Eur J Gastroenterol Hepatol. 2012 Jul;24(7):817-23. doi: 10.1097/MEG.0b013e328353fd11. Eur J Gastroenterol Hepatol. 2012. PMID: 22569080 Free PMC article.
Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.
Karchava M, Chkhartishvili N, Sharvadze L, Abutidze A, Dvali N, Gatserelia L, Dzigua L, Bolokadze N, Dolmazashvili E, Kotorashvili A, Imnadze P, Gamkrelidze A, Tsertsvadze T. Karchava M, et al. Among authors: dolmazashvili e. Hepatol Res. 2018 Jan;48(1):36-44. doi: 10.1111/hepr.12890. Epub 2017 Apr 24. Hepatol Res. 2018. PMID: 28258606
Regression of liver fibrosis over a 24-week period after completing direct-acting antiviral therapy in patients with chronic hepatitis C receiving care within the national hepatitis C elimination program in Georgia: results of hepatology clinic HEPA experience.
Dolmazashvili E, Abutidze A, Chkhartishvili N, Karchava M, Sharvadze L, Tsertsvadze T. Dolmazashvili E, et al. Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1223-1230. doi: 10.1097/MEG.0000000000000964. Eur J Gastroenterol Hepatol. 2017. PMID: 28857900
15 results